The invention provides a method for the treatment of a patient having a more severe form of Alzheimer's disease (AD), where the severe form of AD is characterized by pathogenic deposits of amyloid beta peptide (Aβ), comprising the administration of an immunogenic fragment of Aβcapable of inducing an immune response in the form of antibodies to specific to the pathogenic deposits of Aβand, in particular, to neurotoxic forms of Aβincluding N-terminally truncated forms of Aβ. The invention further provides a method for selecting a suitable immunogenic fragment of Aβfor the treatment of a more severe form of AD.
申请公布号
EP2300050(A1)
申请公布日期
2011.03.30
申请号
EP20090790037
申请日期
2009.07.02
申请人
MERCK SHARP & DOHME CORP.
发明人
SAVAGE, MARY, J.;KINNEY, GENE, G.;LIANG, XIAOPING;CITRON, MICHAEL;ROSEN, LAURA, B.